[1] CHAKRABORTY A K, WEISS A. Insights into the initiation of TCR signaling[J]. Nature Immunology, 2014, 15(9): 798-807. DOI: 10.1038/ni.2940. [2] COURTNEY A H, LO W L, WEISS A. TCR signaling: mechanisms of initiation and propagation[J]. Trends in Biochemical Sciences, 2018, 43(2): 108-123. DOI: 10.1016/j.tibs.2017.11.008. [3] WEISS A, LITTMAN D R. Signal transduction by lymphocyte antigen receptors[J]. Cell, 1994, 76(2):263-274. DOI: 10.1016/0092-8674(94)90334-4. [4] CHEN J X, DOROUDI M, CHEUNG J, et al. Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α, 25(OH)2D3[J]. Cellular Signalling, 2013, 25(12): 2362-2373. DOI: 10.1016/j.cellsig.2013.07.020. [5] EUFEMI M, COPPARI S, ALTIERI F, et al. ERp57 is present in STAT3-DNA complexes[J]. Biochemical and Biophysical Research Communications, 2004, 323(4): 1306-1312. DOI: 10.1016/j.bbrc.2004.09.009. [6] GARBI N, TANAKA S, MOMBURG F, et al. Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57[J]. Nature Immunology, 2006, 7(1): 93-102. DOI: 10.1038/ni1288. [7] GARBI N, HÄMMERLING G, TANAKA S. Interaction of ERp57 and tapasin in the generation of MHC class I-peptide complexes[J]. Current Opinion in Immunology, 2007,19(1): 99-105. DOI: 10.1016/j.coi.2006.11.013. [8] HOLBROOK L M, SASIKUMAR P, STANLEY R G, et al. The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function[J]. Journal of Thrombosis and Haemostasis, 2012, 10(2): 278-288. DOI: 10.1111/j.1538-7836.2011.04593.x. [9] GRILLO C, DAMBROSIO C, SCALONI A, et al. Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors[J]. Free Radical Biology and Medicine, 2006, 41(7):1113-1123. DOI: 10.1016/j.freeradbiomed.2006.06.016. [10] NEMERE I. The 1, 25D3-MARRS protein: Contribution to steroid stimulated calcium uptake in chicks and rats[J]. Steroids, 2005, 70(5/6/7): 455-457. DOI: 10.1016/j.steroids.2005.02.005. [11] SANSONE P, BROMBERG J. Targeting the interleukin-6/jak/stat pathway in human malignancies[J]. Journal of Clinical Oncology, 2012, 30(9): 1005-1014. DOI: 10.1200/jco.2010.31.8907. [12] CHUNG H, CHO H, PERRY C, et al. Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer[J]. Biomarkers, 2013, 18(7): 573-579. DOI: 10.3109/1354750x.2013.827742. [13] RAMOS F S, SERINO L T R, CARVALHO C M S, et al. PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer[J]. Genetics and Molecular Research, 2015, 14(2): 6960-6967. DOI: 10.4238/2015.june.26.4. |